Genetic and Environmental Determinants of Symptomatic and Asymptomatic Leishmani
有症状和无症状利什曼尼的遗传和环境决定因素
基本信息
- 批准号:8304427
- 负责人:
- 金额:$ 10.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAllelesAmericanAntigensAreaBiological MarkersBiopsyBloodBone MarrowBrazilClinicalCollectionComplexControl LocusCountryCutaneousDiseaseDisease OutcomeDisease ProgressionEpidemiologyEpigenetic ProcessGene ExpressionGenesGeneticGoalsHome environmentHousingHumanHypersensitivity skin testingIL6 geneImmuneImmune responseImmunityImmunogeneticsImmunologicsIndividualInfectionInfection ControlInterleukin-10LeadLeishmaniaLeishmania braziliensisLeishmania infantumLeishmaniasisMolecular ProfilingOutcomeParasite ControlParasitesPathogenesisPathologicPathologyPathway interactionsPhenotypeProphylactic treatmentRecoveryRegulationRiskSand FliesSiteSkinSolidSyndromeT-LymphocyteTestingTherapeutic InterventionTissuesTranscriptUrbanizationVisceralVisceral LeishmaniasisWhole BloodWound Healingbaseclinical phenotypedisorder preventionexhaustiongenetic risk factorgenome wide association studynovelperipheral bloodrepairedresponsetool
项目摘要
Leishmaniasis encompasses a complex of diseases with diverse clinical outcomes that include localized or
widespread cutaneous, mucosal and visceral syndromes. The majority of people infected with Leishmania
control infection and remains asymptomatic. However, the mechanisms that medicate control infection and
whether there is parasite clearance are not known. American tegumentary leishmaniasis (ATL) due to L.
braziliensis evolves with a biased immune response to parasite antigens manifested by high TNFa and INFy
but low IL-10. In contrast, visceral leishmaniasis (VL) presents with high levels of IL-10 and TNFa and low
levels of INFy. In recent studies we have shown that IL6 and loci controlling the wound healing response are
associated with tegumentary leishmaniasis, and that HLA is associated with the outcome of L. i. chagasi
infection. We hypothesize that the clinical spectrum of Leishmania infections is determined by immune
responses regulated locally at the site of infection and reflected in the periphery, providing potential
biomarkers for disease progression or recovery. Major emphases of this proposal will be address the
contrasts between the outcomes of infection with different species of Leishmania and the human host
responses. We propose to study novel pathways of gene expression that are influenced by major genetic
risk factors, allowing us to progress to the identification of signatures that will predict disease outcome that
can be applied clinically in the management or prevention of disease. The major goals of this study are: (1)
To determine the downstream pathways regulated by host genes shown to influence VL and ATL through
transcriptional profiling of infected tissues and peripheral blood; (2) To understand the functional correlates
and epigenetic regulation of IL6 and FLU in ATL; and (3) To identify the immunologic mechanisms
determining the different phenotypes in L. i. chagasi-infection and to define whether variability in host
immune response to Leishmania antigens is due to HLA. These studies will provide infonmation about novel
targets for therapeutic intervention by delineating the mechanisms that lead to parasite control and clearance
and by identifying molecular signatures in the blood or infected tissues that can be targeted.
利什曼病包括具有不同临床结果的复杂疾病,包括局部或局部性利什曼病。
广泛的皮肤、粘膜和内脏综合征。大多数感染利什曼原虫的人
控制感染并保持无症状。然而,控制感染的机制,
是否有寄生虫清除尚不清楚。美国表皮利什曼病(ATL)由L。
巴西人进化为对寄生虫抗原有偏向的免疫应答,表现为高TNF α和INF γ
但IL-10低。相比之下,内脏利什曼病(VL)表现为高水平的IL-10和TNF α,而低水平的IL-10和TNF α。
INFy的水平。在最近的研究中,我们已经表明,IL 6和控制伤口愈合反应的基因座,
与皮肤利什曼病相关,HLA与L. I.恰加斯
感染我们假设利什曼原虫感染的临床谱是由免疫系统决定的。
在感染部位局部调节并反映在外周的反应,提供了潜在的
疾病进展或恢复的生物标志物。这项建议的主要重点是解决
不同种类的利什曼原虫和人类宿主感染的结果之间的对比
应答我们建议研究受主要遗传因素影响的基因表达的新途径,
风险因素,使我们能够进一步识别将预测疾病结果的特征,
可在临床上应用于疾病的管理或预防。本研究的主要目的是:(1)
确定宿主基因调控的下游途径,这些基因通过以下途径影响VL和ATL:
感染组织和外周血的转录谱;(2)了解功能相关性
IL 6和FLU在ATL中的表观遗传学调控;(3)探讨ATL的免疫学机制
确定了L. I.查加斯感染,并确定是否在宿主中的变异性
对利什曼原虫抗原的免疫应答是由于HLA。这些研究将提供有关新的
通过描述导致寄生虫控制和清除的机制,
并通过识别血液或感染组织中可以作为目标的分子特征。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Selma Maria Jeronimo其他文献
Selma Maria Jeronimo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Selma Maria Jeronimo', 18)}}的其他基金
Genetic and Environmental Determinants of Symptomatic and Asymptomatic Leishmani
有症状和无症状利什曼尼的遗传和环境决定因素
- 批准号:
8501135 - 财政年份:2013
- 资助金额:
$ 10.73万 - 项目类别:
Genetic and Environmental Determinants of Symptomatic and Asymptomatic Leishmaniasis
有症状和无症状利什曼病的遗传和环境决定因素
- 批准号:
9315514 - 财政年份:
- 资助金额:
$ 10.73万 - 项目类别:
Genetic and Environmental Determinants of Symptomatic and Asymptomatic Leishmani
有症状和无症状利什曼尼的遗传和环境决定因素
- 批准号:
8724331 - 财政年份:
- 资助金额:
$ 10.73万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 10.73万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 10.73万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 10.73万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 10.73万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 10.73万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 10.73万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 10.73万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 10.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 10.73万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 10.73万 - 项目类别: